News
Read our cutting-edge industry analysis and insights on drug supply, market trends, and procurement patterns across pharmaceuticals, medical supplies, and healthcare distribution.
March 1, 2026
Early-2026 supply risk has narrowed into high-impact categories, with TICE BCG still allocation-managed and manufacturer-specific sterile injectable gaps continuing to affect procurement planning.
Subscribe to Specialist Shortage Insight
AI-driven and proprietary forecasting tools help buyers anticipate disruptions and maintain continuity of critical drug supply.
Join our update list to receive focused shortage intelligence, market movement context, and continuity planning signals for licensed healthcare procurement teams.
